Alethea Capital Management, LLC

In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 13, 2026), Alethea Capital Management, LLC reported 13 stock positions worth $186.1 million. Its top holding was Axsome Therapeutics (AXSM) at 58.9% of the portfolio, followed by SS SPDR BB 1-3M T-Bill ETF (BIL, 31.5%) and Kura Oncology (KURA, 6.7%). Compared with Q4 2025, it opened 3 new positions, sold out of 3, added to 2 and reduced 3. The biggest buy was SS SPDR BB 1-3M T-Bill ETF (BIL, shares +171%) and the biggest sale an exit from Avidity Biosciences (RNAM).

Most Recent 13F
Q2 2026
Location
MERCER ISLAND, WA
CIK
0001549408
Portfolio Value
$186.1M (Q1 2026)
SEC Filing
0001549408-26-000002 ↗ filed May 13, 2026

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q1 2024: $123.1M Q1 2024 Q2 2024: $131.8M Q2 2024 Q3 2024: $138.5M Q3 2024 Q4 2024: $116.8M Q4 2024 Q1 2025: $134.0M Q1 2025 Q2 2025: $132.1M Q2 2025 Q3 2025: $155.4M Q3 2025 Q4 2025: $205.9M Q4 2025 Q1 2026: $186.1M $186.1M Q1 2026 Q2 2026: $241.4M Q2 2026

Holdings 13 stocks · $186.1M

AXSM Axsome Therapeutics Inc. 58.94% 649,114 $109.7M Reduce -2.9%
BIL SS SPDR BB 1-3M T-Bill ETF 31.51% 640,038 $58.7M Add +170.5%
KURA Kura Oncology Inc. 6.68% 1,529,369 $12.4M Add +7.5%
TLT iShares 20+ Year Treasury BD 1.06% 22,831 $2.0M Reduce -1.3%
TEM Tempus AI Inc. Class A 0.77% 31,554 $1.4M No change
RNA Atrium Therapeutics Inc. 0.31% 43,758 $585K New
WFC Wells Fargo & Co. 0.26% 6,030 $480K New
HEDJ Wisdomtree Europe Hedged Equ 0.21% 7,430 $389K No change
GPK Graphic Packaging Holding Co. 0.09% 16,330 $162K New
SPY SS SPDR S&P 500 ETF Trust-US 0.07% 190 $124K Reduce -98.6%
IMRX Immuneering Corp. Class A 0.06% 22,935 $121K No change
TASEKO MINES LTD 0.03% 10,000 $65K No change
LPRO Open Lending Corp. 0.01% 12,000 $15K No change

Options reported separately and not counted above: SPY puts ($8.8M).

Portfolio Sells Q4 2025 → Q1 2026

RNAM Avidity Biosciences Inc. Sold out 0.00% −15.62
SPY SS SPDR S&P 500 ETF Trust-US Reduce -98.6% 0.07% −4.54
CDTX Cidara Therapeutics Inc. Sold out 0.00% −0.50
AXSM Axsome Therapeutics Inc. Reduce -2.9% 58.94% −0.36
RSPU Invesco S&P 500 Equal Weight Sold out 0.00% −0.10
TLT iShares 20+ Year Treasury BD Reduce -1.3% 1.06% +0.08

Portfolio Buys Q4 2025 → Q1 2026

BIL SS SPDR BB 1-3M T-Bill ETF Add +170.5% 31.51% +21.01
RNA Atrium Therapeutics Inc. New 0.31% +0.31
WFC Wells Fargo & Co. New 0.26% +0.26
GPK Graphic Packaging Holding Co. New 0.09% +0.09
KURA Kura Oncology Inc. Add +7.5% 6.68% −0.50

Options Activity Q4 2025 → Q1 2026

SPY SS SPDR S&P 500 ETF Trust-US put New 13,500 $8.8M

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 41$241.4MAXSM, BIL, KURA, IMRX, TLT
Q1 2026 13$186.1MAXSM, BIL, KURA, TLT, TEM
Q4 2025 13$205.9MAXSM, RNAM, BIL, KURA, SPY
Q3 2025 33$155.4MAXSM, BIL, RNAM, KURA, TLT
Q2 2025 31$132.1MAXSM, BIL, RNAM, RSPU, KURA
Q1 2025 11$134.0MAXSM, BIL, RNAM, SPY, KURA
Q4 2024 30$116.8MAXSM, BIL, RNAM, KURA, TLT
Q3 2024 30$138.5MAXSM, BIL, RNAM, KURA, TLT
Q2 2024 31$131.8MAXSM, BIL, RNAM, KURA, TLT
Q1 2024 32$123.1MAXSM, BIL, RNAM, KURA, TLT